back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-27 14:17 Tx date 2025-03-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$359,800
+70,000 vol $5.14 each |
260,000 | |
| Filed 2024-05-22 23:41 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$277,200
+70,000 vol $3.96 each |
190,000 | |
| Filed 2023-08-20 12:02 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$35,000
+5,000 vol $7.00 each |
27,200 | |
| Filed 2023-03-31 14:10 Tx date 2023-03-30 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,725
+900 vol $4.14 each |
22,200 | |
| Filed 2023-03-31 14:09 Tx date 2023-03-29 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$37,310
+9,100 vol $4.10 each |
21,300 | |
| Filed 2022-12-12 20:26 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$462,000
+120,000 vol $3.85 each |
120,000 | |
| Filed 2022-12-12 20:25 Tx date 2022-11-01 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-02 19:28 Tx date 2022-11-01 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2022-11-02 19:26 Tx date 2022-11-01 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Brennan, Paul Anthony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,200 | ||
| Filed 2022-05-05 19:38 Tx date 2022-05-04 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$80,000
+50,000 vol $1.60 each |
619,354 | |
| Filed 2022-05-05 19:36 Tx date 2022-05-04 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-50,000 vol |
9,676 | |
| Filed 2022-03-07 20:53 Tx date 2022-03-01 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$247,200
+120,000 vol $2.06 each |
1,110,000 | |
| Filed 2021-05-14 19:10 Tx date 2020-05-20 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$80,000
+50,000 vol $1.60 each |
50,000 | |
| Filed 2021-05-14 19:05 Tx date 2020-05-20 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$80,000
+50,000 vol $1.60 each |
||
| Filed 2021-05-14 18:43 Tx date 2021-05-12 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$20,319
+9,676 vol $2.10 each |
9,676 | |
| Filed 2021-05-14 18:39 Tx date 2019-11-26 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-14 18:25 Tx date 2021-05-12 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$29,998
+19,354 vol $1.55 each |
619,354 | |
| Filed 2020-05-21 14:30 Tx date 2020-05-20 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$80,000
+50,000 vol $1.60 each |
||
| Filed 2021-05-06 20:08 Tx date 2021-04-23 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$198,000
+120,000 vol $1.65 each |
990,000 | |
| Filed 2020-05-21 14:30 Tx date 2020-05-20 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
53 - Grant of warrants
|
$80,000
+50,000 vol $1.60 each |
600,000 | |
| Filed 2020-05-21 14:28 Tx date 2020-05-20 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$62,500
+50,000 vol $1.25 each |
550,000 | |
| Filed 2020-04-15 11:42 Tx date 2020-04-06 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$79,099
+70,000 vol $1.13 each |
870,000 | |
| Filed 2019-11-28 16:16 Tx date 2019-11-26 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
800,000 | ||
| Filed 2019-11-28 16:14 Tx date 2019-11-26 |
$NGEN
NervGen Pharma Corp. |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2015-12-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$15,000
+100,000 vol $0.15 each |
1,100,000 | |
| Filed 2015-12-01 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+100,000 vol $0.30 each |
100,000 | |
| Filed 2015-12-01 Tx date 2015-08-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-30 Tx date 2015-11-27 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$70,000
+500,000 vol $0.14 each |
2,500,000 | |
| Filed 2015-09-04 Tx date 2015-09-02 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$205,000
+1,000,000 vol $0.205 each |
1,000,000 | |
| Filed 2015-09-04 Tx date 2015-08-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-01 Tx date 2015-08-25 |
$IN
InMed Pharmaceuticals Inc. (formerly Cannabis Technologies Inc,) |
Brennan, Paul Anthony
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,000,000 |